VG5-31513-49160
2 vaccinations
1 coded response
7 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 527 / IA
- Registered
- 2021-04-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-06
Dose 1 — Pfizer-BioNTech
-
2021-04-28
Registered in v-safe
- 2021-04-28
-
2021-04-30
Dose 2 — Pfizer-BioNTech
- 2021-05-06
- 2021-05-14
- 2021-06-06
- 2021-06-13
- 2021-07-30
-
2022-04-30
Survey response — 12 months, dose 2MedDRA: Sinusitis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Sinus infectionsMedDRA releases: 2024-11 · check-in free text available
-
2022-04-30
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-03
-
2022-05-06
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-06 | Pfizer-BioNTech | |
| 2 | 2021-04-30 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-30 | Successful 2022-05-06 |
Does not wish to fill out VAERS report |
Free text
Release 11 — 12 months, dose 2
Symptoms: Sinus infections
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release